Wei Li

25PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 08, 2026
Topologically distinct intratumoral heterogeneity scores for predicting high-risk pathological grades in invasive lung adenocarcinoma: A multicenter study across four institutions.

|Aug 08, 2026
Noninvasive Characterization of Tumor Heterogeneity in Locally Advanced Nasopharyngeal Carcinoma: From Progression-Free Survival Prediction to Biological Correlates.

|Mar 25, 2026
Dioscin suppresses tumorigenesis and overcomes radioresistance by promoting ubiquitination-mediated degradation of Mcl-1.

Qi Liang, Xuecheng Wu, Dongyu Li

|Mar 20, 2026
Gracillin overcomes osimertinib resistance in NSCLC via dual inhibition of EGFR and Mcl-1.

Jinzhuang Liao, Qi Liang, Xuecheng Wu

|Oct 02, 2025
Demethoxycurcumin suppresses HK2-mediated glycolysis by targeting PTEN/Akt signaling.

Jinzhuang Liao, Shiming Tan, Shuangze Han

|Jun 18, 2025
Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer.

Ze Mi, Juan Chen, Zhewen Zhang

Pageof 5

Frequent Collaborators

5 joint publications

Xiaoying Li

5 joint publications

Haidan Liu

4 joint publications

Jinzhuang Liao

3 joint publications

Feng Gao